UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) shares shot up 9.3% during mid-day trading on Tuesday after Sanford C. Bernstein raised their price target on the stock from $405.00 to $411.00. Sanford C. Bernstein currently has an outperform rating on the stock. UnitedHealth Group traded as high as $312.43 and last traded at $307.55. 21,966,661 shares were traded during trading, an increase of 123% from the average session volume of 9,840,573 shares. The stock had previously closed at $281.36.
Other equities analysts also recently issued reports about the company. Morgan Stanley lowered their price objective on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research report on Friday, January 23rd. Truist Financial lowered their target price on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a report on Monday, February 2nd. Oppenheimer lowered their target price on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Leerink Partners lowered their target price on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Finally, Piper Sandler reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $363.42.
View Our Latest Research Report on UNH
Key Stories Impacting UnitedHealth Group
- Positive Sentiment: CMS raised 2027 Medicare Advantage payments by ~2.48%, a surprise above street expectations — this directly improves UnitedHealth’s revenue and margin outlook for Medicare Advantage and triggered a broad relief rally across managed-care names. UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears
- Positive Sentiment: Several sell-side analysts raised price targets and upgraded UNH after the CMS decision (example: BofA and Sanford C. Bernstein moves), contributing to the near-term re-rating and higher trading volume. UnitedHealth Price Target Raised to $337 by BofA After Medicare Advantage Rate Finalization
- Positive Sentiment: Street research and note-writers are quantifying meaningful upside from the CMS move (several pieces estimate billions in incremental revenue/operating profit and reduced downside risk), which supports expectations for margin recovery driven by UnitedHealth’s scale and Optum capabilities. UnitedHealth Could Reprice Soon: The Catalyst Is Here
- Neutral Sentiment: Wall Street remains broadly constructive on UNH: ~75% of covering analysts rate the stock bullishly with a consensus target around $355, and UNH is highlighted among hedge-fund favorites — that supports medium-term investor interest but already implies some upside is priced in. Analysts Remain Confident in UnitedHealth (UNH)’s Growth Initiatives Outside of Its Main Insurance Operations
- Neutral Sentiment: Recent fundamental context: UnitedHealth beat Q4/most-recent EPS estimates and provided FY-level guidance, which underpinned confidence before the CMS news — but consensus EPS forecasts remain materially higher than some boutique analyst raises. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
- Negative Sentiment: Caution: commentators warn the Medicare tailwind may be partially priced in after the large one-day rally and the stock faces near-term catalysts (upcoming quarterly results) that could reintroduce volatility if guidance or cost trends disappoint. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
- Negative Sentiment: Macroeconomic and cost risks remain (medical-cost inflation, optical/claims mix, and broader interest-rate/market moves). Those factors plus profit-taking after the run-up explain why UNH has pulled back from its intraday highs. UnitedHealth (UNH) Soars 9.4%: Is Further Upside Left in the Stock?
Institutional Investors Weigh In On UnitedHealth Group
Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of UnitedHealth Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock valued at $30,238,162,000 after buying an additional 995,210 shares during the last quarter. State Street Corp boosted its position in shares of UnitedHealth Group by 2.5% during the fourth quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate’s stock valued at $14,931,592,000 after buying an additional 1,119,834 shares during the last quarter. Capital World Investors boosted its position in shares of UnitedHealth Group by 3.8% during the fourth quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock valued at $7,457,723,000 after buying an additional 824,120 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of UnitedHealth Group by 3.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock valued at $6,215,660,000 after buying an additional 680,077 shares during the last quarter. Finally, Capital International Investors boosted its position in shares of UnitedHealth Group by 6.6% during the fourth quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate’s stock valued at $6,158,734,000 after buying an additional 1,155,162 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Performance
The company has a market cap of $278.02 billion, a PE ratio of 23.22, a PEG ratio of 1.28 and a beta of 0.40. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average of $282.36 and a 200-day moving average of $318.95.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion for the quarter, compared to analysts’ expectations of $113.38 billion. During the same quarter in the previous year, the firm earned $6.81 earnings per share. The business’s revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group’s payout ratio is currently 67.02%.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
